Everything below concerns clinical evidence. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
=== First attempts, halting follow-up === When jamming was first attempted by the Germans it was in a much more clever fashion than had been anticipated. The observation that the transmissions of the individual stations were spread out in time, in order to avoid mutual interference, was exploited. A system was designed to send back spurious broadband pulses on a chosen CH station's time slot. The CH operator could avoid this signal simply by changing their time slot slightly, so the jamming was not received. This caused the station's signals to start overlapping another's time slot, so that station would attempt the same cure, affecting another station in the network, and so forth. A series of such jammers were set up in France starting in July 1940, and soon concentrated into a single station in Calais that affected CH for some time. However, the timing of these attempts was extremely ill-considered. The British quickly developed operational methods to counteract this jamming, and these had effectively eliminated the effect of the jamming by the opening of the Battle of Britain on 10 July. The Germans were well on their way to develop more sophisticated jamming systems, but these were not ready for operation until September. This meant that the CH system was able to operate unmolested throughout the Battle, and led to its well-publicized successes. By the opening of the Battle in July the German Luftwaffe operational units were well aware of CH, and had been informed by the DVL that they could not expect to remain undetected, even in clouds.
With a population of 84.7 million according to the 2023 German census, Germany is the most populous member state of the European Union, the second-most populous country in Europe after Russia, and the nineteenth-most populous country in the world. Its population density stands at 236 inhabitants per square kilometre (610 inhabitants/mi2). The fertility rate of 1.36 children born per woman (2024 estimates) is below the replacement rate of 2.1, but slightly above the EU average of 1.34. Since the 1970s, Germany's death rate has exceeded its birth rate. However, the country is witnessing increased birth and migration rates since the early 2010s. Germany has the fourth oldest population in the world, with an average age of 47.8 years.
== Medicinal use == Arnebia densiflora has been investigated for its wound healing abilities. Arnebia densiflora is one of the five species of Boraginaceae family grown in Turkey. Several species of Boraginaceous plants are used as folk medicine in Turkey and eastern Mediterranean countries. The pigmented root of Arnebia densiflora, known locally as 'Eyilik', is added to olive oil and applied on open wounds and cuts in Anatolia. In Malatya, roots of Arnebia densiflora are dipped in butter. After removing the root pieces the butter is mixed with beeswax to prepare an ointment for open wounds. Roots of Arnebia densiflora are also used as a natural-dye to color Anatolian carpets. The medicinal effect might have to do with the high naphthoquinone content in the roots barks.
=== Plant innate immunity === Plants lack specialized immune cells—all plant cells participate in the plant immune response. Chloroplasts, along with the nucleus, cell membrane, and endoplasmic reticulum, are key players in pathogen defense. Due to its role in a plant cell's immune response, pathogens frequently target the chloroplast. Plants have two main immune responses—the hypersensitive response, in which infected cells seal themselves off and undergo programmed cell death, and systemic acquired resistance, where infected cells release signals warning the rest of the plant of a pathogen's presence. Chloroplasts stimulate both responses by purposely damaging their photosynthetic system, producing reactive oxygen species. High levels of reactive oxygen species will cause the hypersensitive response. The reactive oxygen species also directly kill any pathogens within the cell. Lower levels of reactive oxygen species initiate systemic acquired resistance, triggering defense-molecule production in the rest of the plant. In some plants, chloroplasts are known to move closer to the infection site and the nucleus during an infection. Chloroplasts can serve as cellular sensors. After detecting stress in a cell, which might be due to a pathogen, chloroplasts begin producing molecules like salicylic acid, jasmonic acid, nitric oxide and reactive oxygen species which can serve as defense-signals.
Sources: en.wikipedia.org
== Personal life == Since his playing career ended, Bagwell has spent much of his time with his family while sporadically taking coaching and special assignment positions for the Astros. He is married to Rachel Bagwell, his third wife, with whom he has five children in a blended family. Rachel had three children prior to meeting Jeff. Before his marriage to Rachel, Jeff had two daughters, Blake and Bryce. Bagwell married his first wife, model Shaune Bagwell (née Stauffer), in 1992. He later married Ericka Bagwell, with whom he had his two daughters. Rachel Bagwell was the widow of Greater Houston-area hand surgeon Dr. Michael Brown, the owner and founder of Brown Hand Center. In spite of his professional success, Bagwell has stated that he "doesn't enjoy too much of the spotlight" that follows. While giving a tribute to him during the retirement ceremony of his uniform number, longtime friend and former teammate Brad Ausmus noted several little-known facts. "He liked soccer as much as ... baseball" while growing up in Connecticut. He hit three fewer home runs than his boyhood idol, Carl Yastrzemski, who hit 452. "His baseball card says he's six feet tall. He's closer to 5' 10"." Both Bagwell and Ausmus hit 32 triples in their careers. After his playing career, Bagwell was seen with significantly longer hair. Remarked Ausmus, "I want to confirm he does not have hair extensions." In January 2015, Bagwell reportedly sold his home in the Memorial neighborhood of Houston.
=== Cancer and Infectious Diseases === A significant area of LMRT's work involves developing nanomaterials as tools for biological studies and as multifunctional agents for cancer therapies. This includes designing nanoparticles and nanoporous materials that can home in on tumors, signal cellular changes, enhance imaging, or deliver therapeutic components. Early work in 2002, with Erkki Ruoslahti, involved developing phage-derived peptide-targeted nanomaterials for in vivo tumor targeting. More recently, Bhatia, in collaboration with Erkki Ruoslahti and Michael Sailor, has explored engineering beneficial probiotics to detect or treat cancer cells. For over a decade, LMRT has pioneered new technologies in activity-based diagnostics. This includes designing nanosensors with biological molecules, such as peptide barcodes, that can signal the presence of diseases like cancer when interacting with aberrantly active enzymes (proteases) in diseased tissue. These specialized nanoparticles allow for detection via simple tests on urine similar to an at-home pregnancy test, breath, or blood samples. This platform has expanded to detect 12 diseases, including 6 cancer types. Nanosensors can be administered via inhalation, intramuscular injection, and even ingested in the form of probiotic bacteria. The LMRT is also exploring breath-based diagnostics for rapid results and has developed diagnostic tools that use DNA barcodes and CRISPR technology, making cancer diagnostics more affordable and accessible for low- and middle-resource settings.
=== Visual and other effects of hormonal changes === Testosterone will cause an enlargement of the clitoris and possibly has important effects on the growth and maturation of the vestibular bulbs, corpora cavernosa of the clitoris and urethral sponge. Changes of the vulva initiated by estradiol as well as its direct effects also appear to influence the functioning of the lower urinary tract.
Inflammation of the thyroid is called thyroiditis. There are several different kinds of thyroiditis, including Hashimoto's thyroiditis (Hypothyroidism immune-mediated), and subacute thyroiditis (de Quervain's). These may be initially associated with secretion of excess thyroid hormone but usually progress to gland dysfunction and, thus, to hormone deficiency and hypothyroidism. Oral consumption of excess thyroid hormone tablets is possible (surreptitious use of thyroid hormone), as is the rare event of eating ground beef or pork contaminated with thyroid tissue, and thus thyroid hormones (termed hamburger thyrotoxicosis or alimentary thyrotoxicosis). Pharmacy compounding errors may also be a cause. Amiodarone, an antiarrhythmic drug, is structurally similar to thyroxine and may cause either under- or overactivity of the thyroid. Postpartum thyroiditis (PPT) occurs in about 7% of women during the year after they give birth. PPT typically has several phases, the first of which is hyperthyroidism. This form of hyperthyroidism usually corrects itself within weeks or months without the need for treatment. A struma ovarii is a rare form of monodermal teratoma that contains mostly thyroid tissue, which leads to hyperthyroidism. Excess iodine consumption, notably from algae such as kelp. Thyrotoxicosis can also occur after taking too much thyroid hormone in the form of supplements, such as levothyroxine (a phenomenon known as exogenous thyrotoxicosis, alimentary thyrotoxicosis, or occult factitial thyrotoxicosis).
Dry needling, also known as trigger point dry needling and intramuscular stimulation, is a treatment technique used by various healthcare practitioners, including physical therapists, physicians, and chiropractors, among others. Acupuncturists usually maintain that dry needling is adapted from acupuncture, but others consider dry needling as a variation of trigger point injections. It involves the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain, including pain related to myofascial pain syndrome. Dry needling is mainly used to treat myofascial trigger points, but it is also used to target connective tissue, neural ailments, and muscular ailments. The American Physical Therapy Association defines dry needling as a technique used to treat dysfunction of skeletal muscle and connective tissue, minimize pain, and improve or regulate structural or functional damage. There is conflicting evidence regarding the effectiveness of dry needling. Some results suggest that it is an effective treatment for certain kinds of muscle pain, while other studies have shown no benefit compared to a placebo; however, not enough high-quality, long-term, and large-scale studies have been done on the technique to draw clear conclusions about its efficacy. Currently, dry needling is being practiced in the United States, Canada, Europe, Australia, and other parts of the world.
Sources: en.wikipedia.org
The Indochinese spitting cobra (Naja siamensis) is a venomous spitting cobra whose venom consists of postsynaptic neurotoxins, metalloproteinases, powerful cardiotoxins, with cytolytic activity, and Phospholipase A2 with a diversity of activities. The LD50 of its venom is 1.07–1.42 mg/gram of mouse body weight. Cranial palsy and respiratory depression are reported to be more common after bites by Naja siamensis than by Naja kaouthia. Indochinese spitting cobras will use their venom for self-defense with little provocation, and as the name implies, are capable of spitting venom when alarmed, often at the face and eyes of the animal or human threatening them. A case report in the literature describes pain and irritation of the eyes, bilateral redness, excessive tear production and whitish discharge, with superficial corneal opacity but normal acuity.
=== Further === Burnside College ESPA College Gateshead College Harton Academy and Sixth Form Newcastle College Newcastle Sixth Form College Tyne Metropolitan College South Tyneside College Sunderland College
Snakes do not have direct neurological control of the fang sheath, it can only be retracted as the fangs enter a target and the target's skin and body provide substantial resistance to retract the sheath. For these reasons, the pressure balance hypothesis concludes that external factors, mainly the bite and physical mechanics, are responsible for the quantity of venom expelled.
==== AP1 ==== Activation of AP1 factor involves three MAPK signaling pathways. These pathways use a phosphorylation cascade of three successive acting protein kinases to transmit a signal. The three MAPK pathways in T cells involve kinases of different specificities belonging to each of the MAP3K, MAP2K, MAPK families. Initial activation is done by the GTPase Ras or Rac which phosphorylate the MAP3K. A cascade involving the enzymes Raf, MEK1, ERK results in the phosphorylation of Jun, conformational change allows Jun to bind to Fos and hence AP-1 to form. AP-1 then acts as transcription factor. Raf is activated via the second messenger DAG, SOS, and Ras. DAG recruits among other proteins the RAS guanyl nucleotide-releasing protein (RasGRP), a guanine nucleotide exchange factor (GEF), to the membrane. RasGRP activates the small GTPase Ras by exchanging guanosine diphosphate (GDP) bound to Ras against guanosine triphosphate (GTP). Ras can also be activated by the guanine nucleotide exchange factor SOS which binds to the LAT signalosome. Ras then initiates the MAPK cascade. The second MAPK cascade with MEKK1, JNKK, JNK induces protein expression of Jun. Another cascade, also involving MEKK1 as MAPK3, but then activating MKK3 /6 and p38 induces Fos transcription. Activation of MEKK1, additionally to being activated by Ras, involves Slp-76 recruiting the GEF Vav to the LAT signalosome, which then activates the GTPase Rac. Rac and Ras activate MEKK1 and thereby initiate the MAPK cascade.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.